Press release
Global CDMO Market to grow at a CAGR of 7.25% by 2032, Evaluates DelveInsight
Additionally, the growing need for biologics and small molecules, valued for their effectiveness against complex illnesses, is broadening the scope of outsourced drug development and manufacturing. Strategic moves such as mergers, acquisitions, partnerships, and capacity expansions among leading players are further boosting service capabilities and global presence. Together, these factors are set to drive increased reliance on external expertise for efficient, scalable drug development solutions throughout the forecast period from 2025 to 2032.
DelveInsight's "Contract Development Manufacturing Organization Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Contract Development Manufacturing Organization companies actively working in the market.
To know more about why North America is leading the market growth in the Contract Development Manufacturing Organization market, get a snapshot of the report Contract Development Manufacturing Organization Market Trends
https://www.delveinsight.com/report-store/contract-development-manufacturing-organization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contract Development Manufacturing Organization Overview
A Contract Development and Manufacturing Organization (CDMO) is a company that provides comprehensive services to pharmaceutical and biotechnology firms, including drug development, manufacturing, and sometimes packaging. CDMOs help companies bring products from concept to market by offering expertise, advanced facilities, and regulatory compliance support, allowing clients to focus on research and commercialization.
DelveInsight Analysis: The global CDMO market size was valued at USD 233.71 billion in 2024, is projected to grow at a CAGR of 7.25% from 2025 to 2032, reaching USD 407.09 billion by 2032.
Contract Development Manufacturing Organization Market Insights
Geographically, North America is expected to hold the largest share of the CDMO market in 2024, driven by rising cases of chronic conditions like cancer and tuberculosis. Additionally, the benefits offered by CDMOs in optimizing processes are encouraging more pharmaceutical and biotechnology companies to outsource drug development and manufacturing. This approach helps reduce costs, enhance efficiency, and speed up time-to-market, further fueling market growth throughout the forecast period from 2025 to 2032.
To read more about the latest highlights related to Contract Development Manufacturing Organization, get a snapshot of the key highlights entailed in the Contract Development Manufacturing Organization
https://www.delveinsight.com/sample-request/contract-development-manufacturing-organization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Contract Development Manufacturing Organization Market Report
• In May 2025, Lupin Manufacturing Solutions (LMS) announced the strategic realignment of its core assets and long-term vision to seize emerging opportunities in the CDMO sector. By investing in advanced treatment platforms and leveraging India's strong API ecosystem, LMS seeks to strengthen its capabilities and foster sustainable growth in the global contract development and manufacturing market.
• In May 2025, VGXI, Inc., a CDMO focused on plasmid DNA for gene therapies and vaccines, has successfully passed a US FDA inspection at its GMP facility, resulting in the approval of a client's Biologics License Application (BLA). This achievement underscores VGXI's dedication to quality and regulatory compliance.
• In May 2025, Tivic Health® Systems, Inc. entered into a definitive agreement with Scorpius BioManufacturing to finalize GMP manufacturing validation of EntolimodTM, its lead TLR5 candidate for Acute Radiation Syndrome (ARS), in preparation for a BLA submission to the FDA.
• In March 2025, Ayrmid Pharma Ltd. and RoslinCT revealed plans to establish a strategic partnership to manufacture Omisirge, a cell therapy for treating hematologic malignancies, which is marketed in the U.S. by Ayrmid's subsidiary, Gamida Cell Inc.
• In February 2022, China-based CDMO Asymchem Inc. intends to acquire Snapdragon Chemistry, a U.S.-based company specializing in continuous manufacturing and early-stage chemical process development, for a total value of USD 57.94 million. The deal aims to expand Asymchem's business presence in the U.S.
• In February 2022, MilliporeSigma, the U.S. and Canada Life Science division of Merck KGaA, has completed the acquisition of Exelead for approximately USD 780 million in cash. This acquisition is anticipated to enhance the Life Science business's capabilities, positioning it as a leading CDMO within the mRNA value chain.
• Thus, owing to such developments in the market, rapid growth will be observed in the Contract Development Manufacturing Organization market during the forecast period
Key Players in the Contract Development Manufacturing Organization Market
Some of the key market players operating in the Contract Development Manufacturing Organization market include- Patheon (Thermo Fisher Scientific), Catalent,Inc, Laboratoire Elaiapharm, The Lubrizol Corporation, Cambrex Corporation, Recipharm (EQT), Merck & Co., Inc, AGC Biologics, Nerpharma S.r.l, Pfizer CenterOne (Pfizer Inc), EMERGENT, Onyx Scientific Limited, Lonza, Siegfried Holding AG, CordenPharma International, FUJIFILM Diosynth Biotechnologies, Samsung Biologics, Delpharm, Center for Breakthrough Medicines, and WuXi Biologics and others.
Which MedTech key players in the Contract Development Manufacturing Organization market are set to emerge as the trendsetter explore @ Key Contract Development Manufacturing Organization Companies
https://www.delveinsight.com/sample-request/contract-development-manufacturing-organization-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Contract Development Manufacturing Organization Market Landscape
CDMOs are addressing market demands by investing in advanced biologics manufacturing facilities, increasing capacity, and acquiring smaller companies with specialized expertise. These efforts have broadened their service offerings and established them as essential partners in the biopharmaceutical value chain, fueling growth in the CDMO market. For example, in July 2024, Agilent Technologies acquired Biovectra for $925 million, enhancing its CDMO capabilities in biologics, highly potent APIs, and gene editing. This acquisition not only expanded Agilent's service portfolio but also strengthened its position in the biologics and gene therapy sectors.
Together, these developments are driving growth in the biologics segment and serving as a key catalyst for the overall expansion of the global CDMO market.
Scope of the Contract Development Manufacturing Organization Market Report
• Coverage: Global
• Study Period: 2022-2032
• Contract Development Manufacturing Organization Market Segmentation By Drug Type: (Small Molecules and Biologics)
• Contract Development Manufacturing Organization Market Segmentation By Service Type: (API and Finished Drug Products)
• Contract Development Manufacturing Organization Market Segmentation By Form Type: (Solids and Liquids)
• Contract Development Manufacturing Organization Market Segmentation By Manufacturing: Clinical Manufacturing and Commercial Manufacturing
• Contract Development Manufacturing Organization Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Contract Development Manufacturing Organization Companies: Patheon (Thermo Fisher Scientific), Catalent,Inc, Laboratoire Elaiapharm, The Lubrizol Corporation, Cambrex Corporation, Recipharm (EQT), Merck & Co., Inc, AGC Biologics, Nerpharma S.r.l, Pfizer CenterOne (Pfizer Inc), EMERGENT, Onyx Scientific Limited, Lonza, Siegfried Holding AG, CordenPharma International, FUJIFILM Diosynth Biotechnologies, Samsung Biologics, Delpharm, Center for Breakthrough Medicines, and WuXi Biologics and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global CDMO Market to grow at a CAGR of 7.25% by 2032, Evaluates DelveInsight here
News-ID: 4140658 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Manufacturing
Manufacturing the Future: Exploring the In-Space Manufacturing Market
Rapid improvements in space technology have created new opportunities for in-space production, transforming the space sector. The in-space manufacturing sector is expanding rapidly as space agencies and private companies investigate ways to manufacture products and structures in space. According to MarketsandMarkets' thorough market research analysis, the worldwide in-space manufacturing market is predicted to expand significantly in the next years. In this blog article, we will evaluate the recent trends and…
Global Miscellaneous Market by Types (Gasket, Packing, and Sealing Device Manufa …
The global Miscellaneous market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Global Miscellaneous Market overview
Miscellaneous Market research report offers great insights into the market and consumer data and their interpretation through various figures and graphs.
Miscellaneous markets have experienced significant growth in recent years. The main reason for this is the increasing…
Smart Factory Transforming from “Manufacturing” to “Intelligent Manufactur …
The concept of “Industry 4.0” was officially announced by the German government in 2013 at the Hannover Messe. Since then, its influence has taken the world by storm. From steam mechanization to power automation to data informatization, the Industry 4.0, driven by “intelligentization”, will completely subvert the expectations, changing perceptions of productivity and production relations in the traditional manufacturing industry by way of qualitative change – an immortal monument, perhaps,…
Additive & Conventional Manufacturing – Hybrid Manufacturing Techniques From C …
Croft Filters, based in Warrington, England, have been supplying custom filtration and separation solutions for over 31 years. Over this time, Croft has developed a reputation for their quality, bespoke service through manufacturing a variety of products for specific requirements. These products have included Filtration Cones, Baskets & Screens, Disc Filters and Filtration Housings amongst others, and they are made with Wire Mesh, Wedge Wire and Perforated Plate, depending on…
Digital Meter Market 2017 - Al-Jon Manufacturing, Environmental Manufacturing, H …
The Global Digital Meter Market 2017 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Digital Meter industry. First, "Global Digital Meter Industry 2017" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Digital Meter industry chain structure.
Major Companies Covered in this report:-
Al-Jon Manufacturing
Heitman Laboratories
Kws Manufacturing Company
Kmb Systems
Obvius Holdingd Llc
Lubecorp Manufacturing
Quadlogic…
Competitive Segmentation of Global Mixed-mode Manufacturing Market 2016 Industry …
The market research report titled Mixed-mode Manufacturing Market Research Report 2016 provides a detailed overview of the global Mixed-mode Manufacturing market, in terms of crucial market factors such as the demand drivers, challenges, market segments, key companies, and the recent market trends. The quantitative and the qualitative information presented in this research study is based on primary and secondary sources of information. Moreover, much of the information contained in this…
